It is the mesylate salt form of eprosartan, a non-biphenyl, non-tetrazole, nonpeptide angiotensin II antagonist with antihypertensive activity. Starting with a modest beginning in the year 2004, we are one of the leading organizations engaged in offering Eprosartan Mesylate. It is used for the treatment of high blood pressure. It acts on the renin-angiotensin system in two ways to decrease total peripheral resistance. The compound blocks the binding of angiotensin II to AT1 receptors in vascular smooth muscle, causing vascular dilatation. Eprosartan Mesylate inhibits sympathetic norepinephrine production, further reducing blood pressure.
Product Name : Eprosartan Mesylate
Chemical Names : Teveten; Eprosartan methanesulfonate; Eprosartan (mesylate); Eprosartan mesilate; Eprosartan mesylate dihydrate; Eprosartan Monomethanesulfonate; Futuran; Navixen; Regulaten; Tevetenz;
Molecular Formula : C24H28N2O7S2
Molecular Weight : 520.615 g/mol
IUPAC Name : 4-[[2-butyl-5-[(E)-2-carboxy-3-thiophen-2-ylprop-1-enyl]imidazol-1-yl]methyl]benzoic acid;methanesulfonic acid
CAS Number : 144143-96-4
Parent Compound : Eprosartan (CID 5281037)